Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men

被引:197
作者
Bouché, C
Rizkalla, SW
Luo, J
Vidal, H
Veronese, A
Pacher, N
Fouquet, C
Lang, V
Slama, G
机构
[1] Hop Hotel Dieu AP, INSERM U341, Dept Diabet, F-75004 Paris, France
[2] INSERM U449, Lyon, France
[3] Danone Vitapole, Le Plessis Robinson, France
关键词
D O I
10.2337/diacare.25.5.822
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To evaluate whether a 5-week low-glycemic index (LGI) diet versus a high-glycemic index (HGI) diet can modify glucose and lipid metabolism as well as total fat mass in nondiabetic men. RESEARCH DESIGN AND METHODS - in this study, 11 healthy men were randomly allocated to 5 weeks of an LGI or HGI diet separated by a 5-week washout interval in a crossover design. RESULTS - The LGI diet resulted in lower postprandial plasma glucose and insulin profiles and areas under the curve (AUCs) than the HGI diet. A 5-week period of the LGI diet lowered plasma triacylglycerol excursion after lunch (AUC, P < 0.05 LGI vs. HGI). These modifications were associated with a decrease in the total fat mass by similar to700 g (P < 0.05) and a tendency to increase lean body mass (P < 0.07) without any change in body weight. This decrease in fat mass was accompanied by a decrease in leptin, lipoprotein lipase, and hormone-sensitive lipase RNAm quantities in the subcutaneous abdominal adipose tissue (P < 0.05). CONCLUSIONS - We concluded that 5 weeks of an LGI diet ameliorates some plasma lipid parameters, decreases total fat mass, and tends to increase lean body mass without changing body weight. These changes were accompanied by a decrease in the expression of some genes implicated in lipid metabolism. Such a diet could be of benefit to healthy, slightly overweight subjects and might play a role in the prevention of metabolic diseases and their cardiovascular complications.
引用
收藏
页码:822 / 828
页数:7
相关论文
共 32 条
[1]  
Agus MSD, 2000, AM J CLIN NUTR, V71, P901
[2]  
*AM DIAB ASS, 1999, DIABETES CARE S, V1, P42
[3]   Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients [J].
Auboeuf, D ;
Rieusset, J ;
Fajas, L ;
Vallier, P ;
Frering, V ;
Riou, JP ;
Staels, P ;
Auwerx, J ;
Laville, M ;
Vidal, H .
DIABETES, 1997, 46 (08) :1319-1327
[4]   DIETS CONTAINING HIGH AMYLOSE VS AMYLOPECTIN STARCH - EFFECTS ON METABOLIC VARIABLES IN HUMAN-SUBJECTS [J].
BEHALL, KM ;
SCHOLFIELD, DJ ;
YUHANIAK, I ;
CANARY, J .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1989, 49 (02) :337-344
[5]   EFFECT OF LONG-TERM CONSUMPTION OF AMYLOSE VS AMYLOPECTIN STARCH ON METABOLIC VARIABLES IN HUMAN-SUBJECTS [J].
BEHALL, KM ;
HOWE, JC .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1995, 61 (02) :334-340
[6]   POSTPRANDIAL MODULATION OF LIPOPROTEIN-LIPASE IN RATS WITH INSULIN-RESISTANCE [J].
BOIVIN, A ;
MONTPLAISIR, I ;
DESHAIES, Y .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1994, 267 (04) :E620-E627
[7]   LOW-GLYCEMIC INDEX FOODS IMPROVE LONG-TERM GLYCEMIC CONTROL IN NIDDM [J].
BRAND, JC ;
COLAGIURI, S ;
CROSSMAN, S ;
ALLEN, A ;
ROBERTS, DCK ;
TRUSWELL, AS .
DIABETES CARE, 1991, 14 (02) :95-101
[8]  
Brand Miller J., 1996, GI FACTOR
[9]  
BYRNES SE, 1995, J NUTR, V125, P1430
[10]  
DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214